Apotea AB (publ) (STU:V30) Accounts Payable: €70.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:V30 Apotea AB (publ) STU:V30
26 GF Score
Price €6.61
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Accounts Payable?

Apotea AB (publ) STU:V30 -0.97% 26 Accounts Payable is €70.2 Mil as of Jun. 2026. GuruFocus rates STU:V30 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Accounts Payable for the quarter that ended in Jun. 2026 was €70.2 Mil.

Apotea AB (publ)'s quarterly Accounts Payable increased from Dec. 2025 (€53.7 Mil) to Mar. 2026 (€68.5 Mil) and increased from Mar. 2026 (€68.5 Mil) to Jun. 2026 (€70.2 Mil).

Apotea AB (publ)'s annual Accounts Payable declined from Dec. 2023 (€48.8 Mil) to Dec. 2024 (€48.6 Mil) but then increased from Dec. 2024 (€48.6 Mil) to Dec. 2025 (€53.7 Mil).

Apotea AB (publ) Accounts Payable Related Terms

Apotea AB (publ) Accounts Payable Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Accounts Payable Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
42.59 42.19 48.82 48.63 53.67

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.34 76.89 53.67 68.48 70.18
STU:V30
26GF Score
Apotea AB (publ) STU:V30
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €70.2 Mil mean?
Apotea AB (publ) (STU:V30) has a Accounts Payable of €70.2 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Accounts Payable too high?
Apotea AB (publ)'s current Accounts Payable is €70.2 Mil. Overall, Apotea AB (publ) has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Accounts Payable compare to competitors?
Apotea AB (publ)'s Accounts Payable of €70.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Accounts Payable is €70.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (STU:V30) has a current Accounts Payable of €70.2 Mil. The current Accounts Payable is €70.2 Mil. Apotea AB (publ)'s overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Apotea AB (publ) (STU:V30), the current Accounts Payable is €70.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:Sweden
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
26GF Score

Get the complete analysis for STU:V30

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.61
Price